Related references
Note: Only part of the references are listed.Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)
Simon Peter Gampenrieder et al.
BREAST CANCER RESEARCH (2019)
MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
Huimin Li et al.
BREAST (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Imaging Neoadjuvant Therapy Response in Breast Cancer
Amy M. Fowler et al.
RADIOLOGY (2017)
Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis
Yan-Lin Gu et al.
CLINICAL BREAST CANCER (2017)
MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
Mette S. van Ramshorst et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer
Gaiane M. Rauch et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
Nola M. Hylton et al.
RADIOLOGY (2016)
Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
Claudette E. Loo et al.
BREAST CANCER RESEARCH (2016)
Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
Patricia Cortazar et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype
Eun Sook Ko et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Magnetic resonance imaging in breast cancer treated with neoadjuvant chemotherapy: Radiologic-pathologic correlation of the response and disease-free survival depending on molecular subtype
S. Cruz Ciria et al.
RADIOLOGIA (2014)
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
Michael L. Marinovich et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
